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Abstract
Background: Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort study within which the
Project to Enhance ALSPAC through Record Linkage (PEARL) was established to enrich the ALSPAC resource through
linkage between ALSPAC participants and routine sources of health and social data. PEARL incorporated qualitative
research to seek the views of young people about data linkage, including their opinions about appropriate safeguards
and research governance. In this paper we focus on views expressed about the purpose and composition of research
ethics committees.
Methods: Digitally recorded interviews were conducted with 48 participants aged 17–19 years. Participants
were asked about whether medical research should be monitored and controlled, their knowledge of research
ethics committees, who should sit on these committees and what their role should be. Interview recordings
were fully transcribed and anonymised. Thematic analysis was undertaken, assisted by the Framework
approach to data management.
Results: The majority of interviewees had little or no specific knowledge of ethics committees. Once given
basic information about research ethics committees, only three respondents suggested there was no need for
such bodies to scrutinise research. The key tasks of ethics committees were identified as monitoring the
research process and protecting research participants. The difficulty of balancing the potential to inhibit
research against the need to protect research participants was acknowledged. The importance of relevant
research and professional expertise was identified but it was also considered important to represent wider
public opinion, and to counter the bias potentially associated with self-selection possibly through a selection
process similar to ‘jury duty’.
Conclusions: There is a need for more education and public awareness about the role and composition of
research ethics committees. Despite an initial lack of knowledge, interviewees were able to contribute their
ideas and balance the rights of individuals with the wider benefits from research. The suggestion that public
opinion should be represented through random selection similar to jury duty may be worth pursuing in the
light of the need to ensure diversity of opinion and establish trust amongst the general public about the use
of ‘big data’ for the wider public good.
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Background
Purpose and composition of research ethics committees
Medical research, in particular research that involves the
secondary use of medical records, is regulated by a range
of independent oversight bodies whose role is to ensure
that only research that is both ethical and compliant
with all relevant legislation and official guidance is
permitted. These include: research ethics committees
(RECs) with a general role of scrutiny towards research
proposals in relation to recognised ethical standards
which include respecting the dignity, rights, safety and
well-being of the people who take part; bodies with a
gatekeeping role in relation to requests to access specific
research data resources [1]; bodies with a remit to en-
sure compliance with the legislative framework around
secondary use of data from medical records in research
[2], and; study level ‘patient and public involvement’
committees, which include those providing advice on re-
search ethics [3], management and data usage [4].
International and national guidance has been provided
about the purpose and composition of such bodies [5, 6].
The main responsibility is to protect research participants,
but potential risks and benefits for the wider community
are also taken into account. Committees have the au-
thority to approve, reject or stop studies or require
modifications to research protocols. Specific tasks in-
clude: identifying and weighing up the risks and poten-
tial benefits of research; evaluating the process and
materials to be used for seeking participants’ informed
consent; assessing recruitment procedures and any in-
centives or coercive behaviour towards participants;
considering measures for patient or participant involve-
ment in the research design, and; evaluating risks to
participants’ confidentiality. In some circumstances com-
mittees make judgements around competing priorities,
particularly in circumstance where seeking individual con-
sent is either impractical or likely to introduce bias. These
priorities may include balancing the imperative to minim-
ise risk of inadvertent disclosure of identifiable sensitive
information against the priority to use data effectively and
efficiently to increase the health of the public.
Established guidance states that membership of over-
sight committees should include sufficient expertise and
competence to undertake the committee’s primary pur-
pose [5, 6]. For example, in the case of RECs, expertise
and experience is required to enable the rationale, aims,
objectives and design of research proposals to be recon-
ciled with the dignity, rights, safety and well-being of po-
tential research participants. Individuals with relevant
medical or scientific expertise are required to assess the
procedures to be employed, potential consequences for
participants, and the scientific validity of the study de-
sign. But some risks and benefits, for example relating to
cultural or legal issues, may be more easily identified
and assessed by members with other qualifications or
professional expertise. As well as containing ‘expert’
members, RECs are generally expected to include ‘lay’
members who reflect public opinion and are able to as-
sess the suitability of the information that will be given
to prospective participants as part of the informed-
consent process. Social diversity (including factors such
as age, gender, ethnicity, socio-economic status and dis-
ability) should ideally be reflected in the committee so
that decisions are not dominated by a single perspective
or vested interests. In practice, however, this diversity of
membership and perspectives may be difficult to achieve.
It has been argued, for example, that a preponderance of
institutional or scientific members may result in an at-
mosphere that feels intimidating for community repre-
sentatives and other minority members [7].
Data linkage
An important ethical issue for the research community,
and wider society, is the secondary use of data that is
routinely collected for administration purposes. Al-
though not acquired for the purpose of conducting
health research, these data can be valuable for epidemio-
logical research for several reasons. These data may be
easier to access and more accurate than, for example, in-
formation collected in self-report questionnaires [8].
Data linkage can be a cost efficient way to follow up par-
ticipants, and can contribute information that would
otherwise be missing. It can also inform statistical
methods for dealing with missing data in study samples
[9]. Information from different sources, about the same
people, can help to establish connections between
health, behaviour, the environment and other risk factors
[10–13]. The benefits gained from data linkage tend to
increase with the quality and quantity of data available.
The potential to derive benefits from data linkage
needs to be balanced against the risks to participants in-
cluding, for example, the threat to privacy. Although re-
cords are usually identifiable at the point of linkage,
many of the concerns about privacy can be addressed if
anonymized linkage technologies are used [14–16] or if
suitable governance models can be established using
frameworks such as ‘Data Safe Havens’ which provide
protections equating to effectively anonymised data
where configured appropriately [17, 18]. However, Laurie
et al. suggest that protection of privacy is never absolute,
and this should be acknowledged [19]. They argue that
responsible data linkage requires a proportionate and
adaptable approach, with public and stakeholder engage-
ment, and mutual agreement about the tenets of good
practice. Such an approach is likely to be facilitated by
ethical review that is proportionate to the scale and
complexity of the research proposed, and includes public
and professional opinion in reaching decisions.
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ALSPAC and PEARL
Avon Longitudinal Study of Parents and Children
(ALSPAC) is the largest birth cohort with detailed bio-
logical and behavioural data from before birth to early
adulthood in the world (www.alspac.bris.ac.uk). ALSPAC
recruited women resident in and around the city of
Bristol, UK with expected dates of delivery between 1st
April 1991 and 31st December 1992. The total sample
size included 15,247 pregnancies of which 14,701 babies
were alive at 1 year of age [20]. Participants have been
regularly assessed since then, mainly through question-
naires and clinics and analysis of biological and genetic
samples. The study website describes the resource in more
depth and contains details of all the data that is available
through a fully searchable data dictionary (http://www.bri-
s.ac.uk/alspac/researchers/data-access/data-dictionary/).
Within the main ALSPAC study, the Project to En-
hance ALSPAC through Record Linkage (PEARL) seeks
to gain consent for linking ALSPAC participants to
routinely-collected social and health data, and establish
appropriate methods for this data linkage [21]. PEARL
was established to enhance the ALSPAC database, im-
prove strategies to reduce bias resulting from missing
data, and enable prospective follow-up that minimises
the burden to participants and is cost-efficient. PEARL
incorporated qualitative research to seek the views of
young people about data linkage, including their opin-
ions about appropriate safeguards and research govern-
ance. In this paper we focus on the qualitative data
relating to the purpose and composition of research eth-
ics committees in monitoring medical research, particu-
larly where this involves data linkage.
Methods
Recruitment
The recruitment strategy for the qualitative study aimed
to include young people with differing backgrounds and
levels of participation in the ALSPAC study. An initial
random sample was supplemented by a purposive sam-
ple based on random selection within specific sub-
cohorts: i) low socio-economic status i.e. living in areas
within the two most deprived quintiles as defined by the
Index of Multiple Deprivation, ii) history of low partici-
pation in ALSPAC, and iii) ‘care cases’ highlighted by a
study administration flag to indicate sensitivity in rela-
tion to health or family circumstances). One of the
authors (AB), who has a trusted role within ALSPAC,
undertook the purposive sampling using linked educa-
tion records and information derived from the ALSPAC
administrative database, and operating within the Data
Safe Haven. These participants were blinded to the
purposive sampling.
Potential participants were sent an information leaflet
and a letter of invitation, including a reply slip and pre-
paid envelope to return if they were willing to be inter-
viewed. One reminder was sent. Those who expressed
an interest were contacted by the researcher (LB) who
telephoned to arrange a face-to-face interview. Before
the interview, written consent was obtained. The
ALSPAC Ethics and Law Committee (Reference number
E200905) gave ethical approval for the study.
Interviews
Participants chose whether to be interviewed at home,
in a public place such as a café, or in a private room at
the University of Bristol. One researcher (LB) conducted
all the interviews, which were digitally recorded. The
interview topic guide was shaped by relevant literature,
expertise within the research team, and issues that
arose as interviewing progressed. Explanations were
provided at key points during the interview, including
sketching and discussing diagrams, to aid understand-
ing of key issues relating to different types of consent
and record linkage.
On the topic of research governance the topic guide
included the following questions: Do you think that
medical research is monitored and controlled; Who do
you think does it; Is it important that research is con-
trolled; Who do you think should do the monitoring;
What kinds of safeguards do you think are in place to
make sure the researchers are properly qualified and that
the research they are doing is good; Have you heard of
ethics committees; What do you think they might do;
When considering this type of research (on medical re-
cords, data linkage) what kind of things do you think
they should think about; Who do you think should sit
on these committees?
Prompts and explanations were provided, depending
on the needs of the individual interviewees. Where par-
ticipants had not heard of research ethics committees, a
brief description was provided of the oversight arrange-
ments related to medical research in general and
research involving the secondary use of administrative
data in particular.
Analysis
Interview recordings were fully transcribed and anon-
ymised by removing any information that might identify
participants. Framework methodology was used to aid
thematic analysis of the large qualitative dataset [22, 23].
One researcher (SA) created a primary chart with a row
for each participant and columns containing original text
about monitoring research and research ethics. This
chart was streamlined as analysis progressed. Key terms
and phrases were coded and retained, while repetition and
extraneous text were removed. For this paper, the process
of summarising and coding the data focussed on three
main issues: participants’ knowledge about whether and
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how medical research is monitored; understanding of the
role of ethics committees, and; views about the compos-
ition of ethics committees. Separate charts were compiled
for each of these three broad areas, and similarities and
differences in the views of participants were explored. An
illustrative section of a chart is given in Table 1. A second
qualitative researcher (RC) examined the charts to check
interpretations which were discussed and agreed by all
authors.
Results
Participants
For the main study, 55 young people were interviewed but
in seven interviews there was no discussion of ethics com-
mittees: where time was short, or a young person was
struggling to understand concepts, priority was given to
explaining and discussing data linkage and consent proce-
dures. This paper focusses on the responses of 48 young
people of whom 75 % had participated in the ALSPAC
study from birth, 92 % were White British and 58 % were
female. Just over half (54 %) of the interviewees lived in
more disadvantaged areas by IMD score, and 10 % were
disabled or had a long-term illness (Table 2).
Knowledge of ethics committees
The majority of interviewees had little or no specific
knowledge of ethics committees. Nevertheless, there ap-
peared to be an implicit assumption that there was a
system for checking the activities of researchers:
Well I’ve always assumed there was a system …
Because um after 10, 20 years (laughs) you almost
expect there to be some kind of system in, in place.
(Interview 17)
One young person, who was not aware of ethics com-
mittees, felt information should be available for those
who were interested.
Maybe people should be made aware. I mean, I don’t
think it’s necessary to throw loads of information
about the whole runnings of everything at people
Table 1 Section of chart relating to the role of ethics
committees
ID Text Code
1 I think it’s very important that they [researchers]
have like a standards and stuff and I mean their
morals I guess, if they’re, they’re important but as
long as they’ve got that, a standard, and there’s
somebody checking that they keep to that standard,
like um a sort of separate body, you know, if that
makes sense? A sort of um governing body, that’s it.
That makes sure that they keep to those standards
and that sort of, you know, ethics code, I guess. …
Um make sure things are being used in the right
way, make sure things you know are ethically used
… how important is the research … [if] other
people’s information needs to be used, whether it
does need to be used, whether there’s another
way of doing it … whether somebody could be
perhaps at risk or something if they do use the
information and stuff like that.
Standards
Morals
Separate body
Right way
Importance
Purpose
Risk
2 Making sure obviously that you’ve got a fair
sample, of a fair, um that every group, every,
all types of people are represented within
the study
Fair sample
Representative
3 Um it’s probably a good thing, check everyone’s
doing everything right … maybe what kind of
records they’re looking at. Um obviously they’re
going to be quite personal things if it’s stuff like
medicals stuff, um but I don’t know. Maybe
checking that people have given their consent
and that all, that the organis- the research
organisation has tried to get that consent, that
kind of thing.
Right way
Type of records
Personal
Consent
Rows and columns continued to include all participants (n = 48)
Table 2 Characteristics of participants (n = 48)
Number
Age
17 years 11
18 years 29
19 years 8
Gender
Female 28
Male 20
Ethnicity
White British 44
Mixed 2
White other 1
Declined to say 1
Employment
Student 35
In work 6
Apprenticeship 1
Unemployed 6
Participation in ALSPAC
Regularly since childhood 36
Infrequent since childhood 5
No previous involvement 7
IMD score
(most deprived) 1 10
2 16
3 6
4 6
(least deprived) 5 10
Disability/long term illness 5
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because one they are not going to read it and it might
just sort of annoy them, like ‘Look how much I’ve got
to read or be told’. And, you know, they might not
really, maybe not even understand or really care either
way. But yes, the option should be there for people to
find out about how it’s all done. (Interview 11)
Of the 11 young people who said that they had heard
of ethics committees, six were unclear where they had
gained the information and five indicated they had
learned about ethics committees at school. For example:
We did it in VIP … Values in Practice … it’s just some
rubbish thing they make you do at school (laughs). It’s
really rubbish … it’s like a combination of geography
and, English, RE and some other stuff thrown in and
it’s just, it talks about things, you know, society and
stuff and about, you know, what’s right, what’s wrong
um about ethics and stuff and that’s where I heard
about it. (Interview 1)
Through biology … Not tons, just yeah, just that they
exist and they’re supposed to be there for our good.
(Interview 37)
The role of ethics committees
Following a brief summary by the interviewer of the pur-
pose of ethics committees, the young people were asked
to consider the value of this role. Only three respon-
dents suggested there was no need for ethics committees
to scrutinise research. One respondent (Interview 30)
was unusual in consistently indicating that he had no
concerns about anyone accessing any of his personal
data without his consent. Other reasons given for not
consulting ethics committees were the difficulty of mon-
itoring what researchers were doing in practice, and the
potential to restrict the research process.
Well you don’t necessarily have to do it [consult an
ethics committee] cos they don’t know that you’re
necessarily actually doing what you say you’re
doing anyway … I mean, I’m sure you are but I’m
just saying like you could be doing something
completely different that they don’t know about.
(Interview 28)
They [researchers] should just do what they say. It
shouldn’t need to be checked up on because they’re
doing research that’s going to help … I think that’s
[ethics application] just too much hassle to the point
where you might just not bother doing the research.
(Interview 29)
The difficulty of balancing the potential to inhibit re-
search against the need to protect research participants
was specifically acknowledged:
It [ethics application], well it’s beneficial. It’s just if it
will, is it too strict? Will it actually stop progress
being made too much? (Interview 32)
It [ethics application] might put some researchers
off trying to do studies but … the usual ethical
guidelines [should be followed] if it’s going to, yeah,
like if it [the research] could have any really bad
consequences afterwards like socially or politically.
(Interview 42)
It was suggested that ethics committees could offer
guidance to researchers. This might be telling re-
searchers “whether it’s OK” (Interview 31) or “you’re
doing it wrong” (Interview 9) to avoid potential scandals:
You’ve got to be kind of over-protective with stuff like
this because some awful case will happen and every-
one will kick up a stink. You only need one awful case
to get into the press. (Interview 45)
The majority of views expressed about the purpose
of ethics committees related to two priorities: moni-
toring the research process and protecting research
participants.
Monitoring researchers
It was suggested that researchers need an external body
to ensure they adhere to the required standards for eth-
ical research:
As long as they’ve got that, a standard, and there’s
somebody checking that they keep to that standard,
like um a sort of separate body, you know, if that
makes sense? A sort of governing body, that’s it, that
makes sure that they keep to those standards … make
sure things are being used in the right way … how
important is the research … whether there’s another
way of doing it … whether somebody could be
perhaps at risk or something if they do use the
information and stuff like that. (Interview 1)
In particular, researchers should not feel they can do
as they please:
Otherwise you would just like do anything … you can
get a bit selfish, not on purpose but like if you really
want to do something. You wouldn’t, kind of like, also
consider other options. (Interview 4)
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Examining the purpose of the research was considered
important:
Just to make sure you’re not like just doing it to be
nosey or whatever, just to see that you’re actually
doing it for like a, like a proper reason. (Interview 25)
I’d say there would probably have to be an overruling
body … Then I mean if it was something that they don’t
agree with, then they might say “No” straightaway. But if
it’s something like a cure for cancer, and you’re getting
an answer, then they might say “Well you can keep going
with this but, once you get to a dead end, then you stop”.
And maybe they, they’d have to have, sort of first, legally
they would be the person who would be able to stop it if
it needed to be stopped. (Interview 38)
This monitoring process was also linked to the effi-
cient use of resources “to like make sure that they do it
properly and don’t waste the money and waste people’s
time” (Interview 10).
I’d want to know that there’s, there’s been something
that mediates it all … we’re not exactly the poorest
country in the world but I’d say that, well I wouldn’t
want to waste money on stuff that’s not necessary.
(Interview 16)
They can decide if it’s worth doing or not … like
how advantageous it would be to the general public
and like how much it would cost and all that.
(Interview 43)
Protecting research participants
A primary role for ethics committees was acknowledged
to be the protection of research participants:
Got to make sure that the participants aren’t going to
be harmed in the study… make sure the information’s
going to be confidential, make sure that the results
aren’t going to have negative effect on society, um got
to ensure that the participants have already had, given
like informed consent, or general consent at least …
they’re some of the ones that I’ve learnt about and
they are the ones that I would think are more
important ones. (Interview 20)
Obviously everybody has a different level of things
that they’re comfortable with … you can’t go in guns
blazing, saying things that are gonna upset the person
you’re trying to get information from. (Interview 37)
Different types of research were thought to require dif-
ferent levels of protection for research participants, and
there were concerns about acquiring data without the
knowledge or consent of the participant:
I think in this [interview] situation I think it [ethical
approval] is a bit over the top like. Sort of like we’re not
giving you blood or anything (laughs) like you’re just
asking me questions … but I think for other things like
medical records and stuff I think it will definitely be
more important … Like if there’s something wrong with
you, like other people shouldn’t really be able to know
that as easily … in that situation like it would be
someone going to get information and I’m not there.
Whereas here I’m choosing what I can, what to say to
you, but I can decide what to say. (Interview 15)
An important aspect of the role of the ethics commit-
tee was to have the “best interest of other people at heart
… then they’d make the decisions that’s like, like for
everybody” (Interview 50). Consideration of the role
inevitably entailed discussion of who sits on ethics com-
mittees and contributes to such decisions.
Composition of ethics committee
Expertise
Relevant research expertise was considered important
including “people that have done research before, so like
they know what they’re doing and what they need to do”
(Interview 6) and “someone who knew about the area of
research to work out whether it was feasible or not”
(Interview 32).
But other types of expertise were also considered
important:
I think probably like judges to be honest actually. Cos
obviously they make quite good judgements (laughs).
Not all the time but sometimes they do, um perhaps
doctors and stuff because you know I guess they know
stuff that was important about research and stuff that’s
important. Maybe, you know, a police person should be
on there because again with like you know safety-ness
and stuff, they’d know about that … and maybe like
accountants and stuff cos you know they seem to be
everywhere so they’re quite important. (Interview 1)
Other experts included: “doctors, psychologists” (inter-
view 14); “a government official maybe, just for like ‘Is it
right with what the government wants to be doing right
now?’ sort of thing” (Interview 38); “a legal representative”
(Interview 15); “human rights person” (Interview 44), and;
“philosophers” (Interview 11). This mixture of expertise
was described by one participant as “a group of geeks
basically (laughs)” (Interview 26).
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Balance and representation
Although expertise was considered important, it was
also felt that wider representation was needed to minim-
ise the influence of vested interests.
I’m thinking there’d be possibly some representatives
from just any job, any sort of people maybe, just to say
how they’d feel if they were being asked those questions
because a scientist will have a vested interest in whether
or not some research will go through won’t they? So
you’d need um, all sorts of people really. Lots of people
who know what this is about, you know, scientists,
researchers themselves, ethics people but also some
people who wouldn’t really have a particular interest
either way. (Interview 11)
It was considered important “to get like a fair repre-
sentation of everyone’s opinions on research” (Interview
42). This could include “poor people and rich people
and middle class people” (Interview 25) and “say you
have got one … far right conservative, you should even
it out with a liberal mind on the other side so that it is
not just too one sided” (Interview 5).
I guess you’d want someone from a different like from
an ethnic background maybe, maybe someone from a
wealthy background. You don’t want all the same type
of people otherwise it’s just not going to be able to
work is it, that’s not really what a committee’s about …
you don’t want people under the same impression, do
you? You want people with different views I guess.
(Interview 18)
Not necessarily just race and gender and age and
things, you probably want people from different job
backgrounds as well. Like people, you wouldn’t want
just people who sat in an office all day, you certainly
want people like shop keepers and um people from like
who have more hands on jobs as well because,
particularly don’t want just educated people I think cos
then, because that, because I think the opinions of
some is, is just the opinion of a small group of people
not the opinion of everybody. (Interview 24)
This wider representation of views might be “in some
proportion to the sort of amounts of that type of person
in the UK” (Interview 33), and would aim to ensure that
“the collective thought that they’ve all come up with is a
fair one” (Interview 45).
Public representation
To support this balance of opinion, and especially to repre-
sent the general public, it was suggested that participation
in ethics committees should be a “bit like jury duty
in a way” (Interview 12), “to have a variety of opin-
ions … some people such as jury duty … a lot of dif-
ferent people” (Interview 9).
It should be like a jury … it’s like a group of people
and like you get, you get told from a random selection
of people. Not like a set group of people each time.
And then it'd be like, they decide … it’s really hard to
choose who should sit on it cos different people have
different opinions, don’t they, about what’s ethical and
what’s not ethical and what’s right and what’s not
right and what should be done. So it needs to be like
how we choose a jury like, random, like different
groups of people rather one set of type of person.
(Interview 19)
The contribution of these members was not expertise
but to represent public opinion:
Because otherwise the researchers are a bit like a, a
clique again. What, what their opinion is might not be
the opinion of everybody. So you need to ask the
opinion of people who aren’t researchers like Joe
Public, which is why, whether or not they feel
comfortable about what things they’re researching.
(Interview 24)
Maybe just one normal person. Like, yeah like one um
person who would say like “Oh I don’t think people
would be willing to take part in that.” (Interview 4)
These members might include “a representative of one
of the people, like one of the people that would be stud-
ied” (Interview 15), which was thought important be-
cause “if something is gonna affect me, I’m gonna wanna
have a say in it” (Interview 37). Alternatively, it might be
“a few kind of like average people” (Interview 43).
It was felt that, for these members, specific expertise
was not needed “so long as they all know what’s ethical
and what’s not that’s fine” (Interview 21). One respond-
ent suggested “give them a test and see if they’re of like
sound of mind and stuff and then … they’d all have dif-
ferent bits of knowledge they could bring to the like
overall opinion” (Interview 43).
“They probably should know, and probably know
better than a lot of the others, because they’ll be
the kind of people that, whose information would
be used probably. So then, if they agree that it’s
all right then probably, I don’t know, the majority
of people would feel that their stuff ’s OK.”
(Interview 47)
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Discussion
Balancing interests
The PEARL study was established specifically in relation
to data linkage to enhance ALSPAC. However, the issues
raised are pertinent to the increasing demand within
medical research for secondary use of data which may
entail linking data from different sources into larger
datasets or using data for purposes not known by the
original study participants [24]. Similar issues also arise
in relation to genetics and genomics research where
there have been calls for consensus on the appropriate
use of archived data and consent procedures for future
unspecified research [25]. More broadly, some of these
issues – particularly representation in committee mem-
bership– tie in with Patient and Public Involvement ini-
tiatives such as INVOLVE [26].
It is argued that research participants require adequate
protection while the cost, time and administrative bur-
den for researchers should be minimised to enable wider
society to reap the benefits of opportunities to exploit
existing data using new innovations in informatics and
particularly ‘data linkage’ infrastructure and methodolo-
gies. This may be a difficult balance to achieve and there
are concerns that if regulations are too stringent they
will hinder, or make impossible, research that contrib-
utes to improving health outcomes and health systems
performance [27]. The Department of Health in the
United Kingdom (UK) has suggested that ‘the duty to
share information can be as important as the duty to
protect patient confidentiality’ (p.21) [28]. The import-
ance of these issues was acknowledged by young people
in the PEARL qualitative study.
The role and composition of ethics committees
Although three-quarters of the interviewees had been
involved in the ALSPAC study from birth, the majority
indicated they had little or no knowledge of ethics com-
mittees. This would suggest that far more needs to be
done to educate and inform young people, and the wider
general public, about the purpose of ethic committees.
However, once given an outline of the role of ethics
committees, the young people contributed a range of in-
teresting and relevant ideas about their purpose and
composition.
Casteleyna et al. [24] suggest ethics committees could
play a key role in assessing competing needs and building
trust in science amongst (potential) study participants and
the wider community. They argue the perceived tension
between privacy and data sharing within health research
should not be overemphasized, as studies have highlighted
public willingness to participate in research with a view to
advancing scientific knowledge in the interests of all. This
is supported by previous PEARL research which showed
participants felt positively about health related research,
believing in the importance of participating in studies
which were conducted for the benefit of the wider public,
although this did not entitle researchers to do whatever
they liked with participants’ data [29].
van Veen [30] suggests the ethical rationale of research
involving data sharing can be based on the principles of
citizenship and solidarity. He argues a good research
governance framework should not establish rules but
principles which provide flexibility, and a fair balance
between the interests of all stakeholders. Such research
governance, he argues, should be developed by re-
searchers together with patients who, as 'biosocial citi-
zens', are the natural allies of researchers against the
'paternalistic attitudes' of some ethicists and regulators.
Burton et al. [17] argue data usage, whilst being con-
sistent with formal ethical and legal requirements, must
also be responsive to emerging issues raised by new re-
search and ethico-legal developments. This responsive-
ness depends upon inclusive structures, representing all
stakeholders including patients or research participants,
that are able to deal with issues in a timely way whilst
ensuring the public and research participants have suffi-
cient trust and confidence to provide data upon which
research and healthcare development depend.
A useful distinction can be made between lay and
community representation on ethics committees [31].
Lay representation refers to members with no scientific
or medical background but who usually have profes-
sional expertise that they contribute to the deliberations
of the committee, for example lawyers, economists or
theologians. They may be quite different from the pa-
tients or participants being researched, although lay and
community representation are often conflated. Interest-
ingly, the young people in the PEARL study did appear to
differentiate between health researchers, other experts,
and “ordinary” or “normal” people and felt there was a
role for each in the deliberations of ethics committees.
This has been implemented within ALSPAC, where mem-
bership criteria of the ALSPAC Ethics & Law Committee
[32] distinguishes between clinicians, professionals, lay
members and study participants (who should comprise
half the membership of the committee). Both ALEC,
and more broadly ALSPAC, are advised by the ALSPAC
Original Cohort Advisory Panel; a committee of study
participants who advise on research management issues.
However, in cases involving the use of health service data,
or the collection of data via direct assessment, the ultimate
decision making lies with NHS committees, and are there-
fore beyond the influence of study patients/participants.
Dyer [33] argues, while the public once trusted experts
simply because of their expertise, the relationship in late
modernity is more complex and contested. He favours
greater public involvement in ethics committees but sug-
gests, if there is a lack clarity about what they are being
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asked to contribute and how, there is a risk of wasting
peoples’ time and endangering trust between experts
and non-experts. Given their potential role in promoting
greater openness and trust, he speculates that members
of the public should be selected as they are for jury ser-
vice where their role would be to assess the elements of
research concerned with social values [33]. Several
young people in the PEARL study also suggested that
public participation in ethics committees might be simi-
lar to jury duty. In England and Wales, the public retain
high levels of trust in the jury system [34] and this may
be an idea worth pursuing in the light of the need to es-
tablish trust amongst the general public in the use of
‘big data’ for the wider public good.
Strengths and limitations
The recruitment strategy resulted in a large sample for a
qualitative study of this kind, and this enhanced diver-
sity. Quotations included in this manuscript were chosen
because they illustrate particularly well the specific
points made. The views expressed are from a range of
participants: of the 48 young people who discussed eth-
ics committees, 29 are directly quoted in this manu-
script, either in longer quotations or phrases/words. Of
these 29 young people: five had a disability or long-term
illness; seven were unemployed; five had never partici-
pated in ALSPAC activities despite being eligible, and
four had only partially participated; nine were in the
lowest socio-economic group and five were in the high-
est. This suggests that the young people from the
purposively chosen sub-groups did not have difficulty
engaging with the topic and expressing their opinions.
Theoretical saturation was achieved, where additional
sampling did not lead to new information relating to the
research questions. Some responses show a level of un-
derstanding and maturity that might not have been ex-
pected from young people who, by their own admission,
had previously not given much consideration to the
topic. The majority of participants had been engaged
with ALSPAC since birth and may have different per-
spectives about research from young people who are not
part of a research cohort. Nevertheless, they expressed a
range of views and raised interesting issues. We should
not, therefore, assume that young people are unable to
understand these topics; the interviews illustrate that
young people can make a valuable contribution to dis-
cussions about research ethics and the deliberations of
ethics committees.
Conclusion
This study suggests that there may be a need for more
education and public awareness about the role and com-
position of research ethics committees. Nevertheless, des-
pite expressing an initial lack of knowledge about ethics
committees, the respondents demonstrated an apparently
sophisticated understanding of the relevant issues and
were able to contribute their ideas and to balance the
rights of individuals with the wider benefits from research.
In terms of the composition of ethics committees, they
expressed the need for expertise but also emphasised the
importance of considering wider views from members of
the general public. Respondents also appeared to recog-
nise the potential for bias if committee members were
predominantly self-selected. Some respondents advocated
recruitment onto ethics committees through a system
similar to jury duty, to ensure diversity of opinion and en-
hance trust amongst the wider public.
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